For the purpose of evaluating BGC, the immediate clinical priority is correction of symptomatic hypocalcemia, hyperphosphatemia, and hypomagnesemia and avoidance of iatrogenic extremes of PTH, rather than pursuit of a specific PTH numeric endpoint. This evidence concerns the gene PTH and Hypocalcemia.